Iterum Therapeutics(ITRM) - 2024 Q4 - Annual Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 (Exact name of Registrant as specified in its Charter) Ireland 98-1283148 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) 3 Dublin Landings, North Wall Quay, Dublin 1, Ireland (Address of principal executive offices) Not applicable (Zip ...